BIO - Bio-Rad Laboratories - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BIO is currently covered by 3 analysts with an average price target of $291.99. This is a potential upside of $55.65 (23.55%) from yesterday's end of day stock price of $236.34.

Bio-Rad Laboratories's activity chart (see below) currently has 71 price targets and 52 ratings on display. The stock rating distribution of BIO is 84.62% BUY and 15.38% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 75.76% with an average time for these price targets to be met of 188 days.

Highest price target for BIO is $390, Lowest price target is $270, average price target is $330.

Most recent stock forecast was given by BRANDON COUILLARD from WELLS FARGO on 17-Apr-2025. First documented stock forecast 06-May-2015.

Best performing analysts who are covering BIO - Bio-Rad Laboratories:

Brandon Couillard Patrick B Donnelly Dan Leonard Jack Meehan

Currently out of the existing stock ratings of BIO, 11 are a BUY (84.62%), 2 are a HOLD (15.38%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$270

$33.66 (14.24%)

$700

17 days ago
(17-Apr-2025)

16/19 (84.21%)

$31.82 (13.36%)

241

Buy

$390

$153.66 (65.02%)

$385

6 months 3 days ago
(31-Oct-2024)

12/23 (52.17%)

$31.81 (8.88%)

149

Buy

$700

$295.94 (73.24%)

$750

2 years 9 months 26 days ago
(08-Jul-2022)

8/12 (66.67%)

$112.28 (23.08%)

170

Buy

$380

$21.55 (6.01%)

$340

5 years 9 months 2 days ago
(02-Aug-2019)

4/4 (100%)

$46.7 (17.50%)

192

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BIO (Bio-Rad Laboratories) average time for price targets to be met?

On average it took 188 days on average for the stock forecasts to be realized with a an average price target met ratio 75.76

Which analyst has the current highest performing score on BIO (Bio-Rad Laboratories) with a proven track record?

BRANDON COUILLARD

Which analyst has the current lower performing score on BIO (Bio-Rad Laboratories) with a proven track record?

JACK MEEHAN

Which analyst has the most public recommendations on BIO (Bio-Rad Laboratories)?

Brandon Couillard works at WELLS FARGO and has 6 price targets and 4 ratings on BIO

Which analyst is the currently most bullish on BIO (Bio-Rad Laboratories)?

Patrick Donnelly with highest potential upside - $295.94

Which analyst is the currently most reserved on BIO (Bio-Rad Laboratories)?

Jack Meehan with lowest potential downside - $21.55

Bio-Rad Laboratories in the News

Q1 2025 Bio Rad Laboratories Inc Earnings Call

Participants Edward Chung; Vice President – Investor Relations; Bio Rad Laboratories Inc Jonathan DiVincenzo; President, Chief Operating Officer; Bio Rad Laboratories Inc Roop Lakkaraju; Chief Financial Officer, Executive Vice President, Principal Financial officer; Bio Rad Laboratories Inc Norman Schwartz; Chairman of the Board, President, Chief Executive Officer; Bio Rad Laboratories Inc Patrick Donnelly; Analyst; Citi...

BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in Aftermarket

Bio-Rad Laboratories, Inc. BIO posted first-quarter 2025 adjusted earnings per share (EPS) of $2.54, which surpassed the Zacks Consensus Estimate of $1.73 by 46.8%. The bottom line increased 10.9% from the prior-year quarter’s level. The quarter’s adjustments primarily eliminate the impacts of certain non-recurring items, such as the amortization of purchased intangibles, restructuring costs and...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?